Portfolio Lab

Haleon plc

  • Stock
  • Ticker HLN
  • ISIN US4055521003
  • NYSE
  • US listing in dollars (ADR)

Consumer, non-cyclical · Household and personal products · United Kingdom

$9.07 +0.22%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Haleon plc since 07/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HLNGlobal equities (VT)

$10,000 grew to $11,199. Global equities (VT): $15,235.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −24.8% in 09/2022, measured from the peak in 08/2022. It took 4 months to get back to the old peak.

1-year return
−3.6%
Return p.a. since 07/2022
+6.4%
Volatility p.a.
22.7%
Largest decline
−24.8%

Financial statements

Amounts in £ millions from the company's annual financial reports, earnings per share in £ per ordinary share

Fiscal year20212022202320242025
Income statement
Revenue9,54510,85811,30211,23311,030
Gross profit5,9506,5776,7476,8247,080
Operating income1,6381,8251,9962,2062,412
Net income1,4391,1191,1111,4751,680
Earnings per share0.150.120.110.160.19
Balance sheet
Total assets34,45134,81534,05534,31532,630
Liabilities7,97118,35817,32618,09116,146
Equity26,48016,45716,72916,22416,484
Cash4146841,0442,2501,324
Long-term debt8710,0038,8008,6407,773
Cash flow
Operating cash flow1,3562,0632,1002,3012,634
Capital expenditure-228-304-234-250-322
Free cash flow1,1281,7591,8662,0512,312

Annual returns

Best year 2024 at +18.0%, weakest 2023 at +4.2%. 3 of 3 full years were positive. * partial year.

Key metrics

Key figures as of 21 Nov 2026 from the company's latest annual financial report, amounts converted to US dollars at the ECB reference rate. Valuation and market cap appear only where price and earnings per share reliably refer to the same share.

Valuation

Market cap
€35bn
Market cap in trading currency
$39.0bn
Enterprise value
$48.5bn
P/E
17.9
P/S
2.69
P/B
1.81
EV/Sales
3.35
EV/EBITDA
–
Earnings yield
5.6%
FCF yield
7.8%

Results (latest fiscal year)

Revenue
$14.5bn
Gross profit
$9.29bn
EBITDA
–
Net income
$2.19bn
Earnings per share
$0.24
Revenue growth
−1.8%
Earnings growth
+15.6%

Profitability

Gross margin
64.2%
Operating margin
21.9%
Net margin
15.1%
Return on equity
10.2%
Return on assets
5.1%

Balance sheet and cash flow

Cash
$1.74bn
Financial debt
$11.3bn
Debt/equity %
52
Current ratio
0.92
Book value per share
$2.41
Operating cash flow
$3.46bn
Free cash flow
$3.03bn

Dividend

Dividend yield
2.15%
Dividend (12 months)
$0.19
Yield (12 months)
2.15%
Payout ratio
37%
Ex-dividend date
14 Aug 2026

Shares and trading

Shares outstanding
8.96bn
Volume
18.0m
Avg. volume 3 months
19.3m
Relative volume
0.9

Price and technicals

Price
$9.07
1 day
+0.2%
52-week high
$11.27
52-week low
$8.57
Distance to 52-week high
−19.5%
Distance to 52-week low
+5.8%
Distance to 50-day line
−2.7%
Distance to 200-day line
−6.2%
RSI (14)
44
Volatility 1M
57.7%

Performance

1 week
−1.1%
1 month
−12.5%
3 months
−10.7%
6 months
−2.4%
YTD
−10.3%
1 year
−4.6%

Dates

Fiscal year end
31 Dec 2025

Frequently asked questions

How has HLN performed since 07/2022?

$10,000 grew to $13,103 by 20 Nov 2026, which is +6.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HLN?

Volatility was 22.7% per year, measured on monthly returns. The largest decline from a peak was −24.8%, with the low in 09/2022.

How does HLN compare with a broad equity ETF?

Over the same period Global equities (VT) returned +13.8% per year at 14.6% volatility, HLN returned +6.4% at 22.7%. The correlation of monthly returns was 0.19; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's depositary receipt (ADR) traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Key figures and financial statements calculated from the company's annual financial reports, without guarantee; key figures converted to US dollars at the ECB reference rate, statements in the currency of the report.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Haleon plc (HLN): Return and risk | Portfolio Lab